RE:New medipharm article gives light on potential revenues.Those MediPharm revenues are based on wholesale sales of extracted products to clients whereas Valens is initially generating tolling revenues by extracting for clients.
Coffeeuke wrote: Medipharm just signed a pretty nice deal, with a guarentee of over $7m in February alone. Gives some insight into the potential gross revenues of their 4 deals. A potential trial of $85m over the next 15 months on those contracts alone is impressive, seems to outline this is based on their current 150k kg capacity. https://www.newcannabisventures.com/cannabis-oil-supplier-medipharm-labs-signs-35-million-minimum-supply-deal-with-canadian-licensed-producer/